Benzinga's Top Initiations

Analysts at Barclays initiated coverage on

with a Equal-weight rating. The target price for Momenta Pharmaceuticals is set to $22. Momenta Pharmaceuticals shares closed at $17.70 on Friday. Cowen & Company initiated coverage on

with a Outperform rating. The target price for Myokardia is set to $24. Myokardia shares closed at $11.83 on Friday. Analysts at Morgan Stanley initiated coverage on

with a Overweight rating. The target price for Himax Technologies is set to $8.50. Himax Technologies shares closed at $7.34 on Friday. JP Morgan initiated coverage on

with a Neutral rating. The target price for Blackstone Group is set to $40. Blackstone Group shares closed at $31.18 on Friday. Analysts at Credit Suisse initiated coverage of

with a Outperform rating. The target price for Myokardia is set to $18. Myokardia shares closed at $11.83 on Friday. Barclays initiated coverage of

with a Overweight rating. The target price for Coherus Biosciences is set to $46. Coherus Biosciences shares closed at $27.61 on Friday. BTIG Researchinitiated coverage on

with a Sell rating. The target price for Match Group is set to $11. Match Group shares closed at $15.20 on Friday. Analysts at Guggenheim Securities initiated initiated coverage on

with a Buy rating. The target price for Revance Therapeutics is set to $55. Revance Therapeutics shares closed at $35.31 on Friday. Analysts at Oppenheimer initiated coverage on

with a Outperform rating. The target price for Adesto Technologies is set to $8. Adesto Technologies shares closed at $5.55 on Friday. Analysts at HSBC initiated coverage on

with a Buy rating. The target price for Copa Holdings is set to $75. Copa Holdings shares closed at $54.54 on Friday.